SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 33.44 |
Enterprise Value ($M) | 21.96 |
Book Value ($M) | 25.57 |
Book Value / Share | 0.56 |
Price / Book | 1.31 |
NCAV ($M) | 25.32 |
NCAV / Share | 0.56 |
Price / NCAV | 1.32 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.25 |
Return on Assets (ROA) | -1.11 |
Return on Equity (ROE) | -1.25 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.24 |
Current Ratio | 3.24 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 36.61 |
Assets | 36.86 |
Liabilities | 11.29 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 10.99 |
Operating Income | -34.07 |
Net Income | -57.53 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -25.58 |
Cash from Investing | 1.21 |
Cash from Financing | 4.19 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Perceptive Advisors Llc | 9.99 | ||
13D | Foundation Fighting Blindness Retinal Degeneration Fund | 8.16 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
16,930 | 51,910 | 32.61 | |
52,082 | 174,847 | 29.79 | |
22,751 | 128,078 | 17.76 | |
29,576 | 126,418 | 23.40 | |
(click for more detail) |
Similar Companies | |
---|---|
INO – Inovio Pharmaceuticals, Inc. | INTS – Intensity Therapeutics, Inc. |
IPA – ImmunoPrecise Antibodies Ltd. | ITRM – Iterum Therapeutics plc |
JAGX – Jaguar Health, Inc. |
Financial data and stock pages provided by
Fintel.io